Insider Trading Alert - NHI, EPR And LFUS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, June 4, 2014, 131 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $500.01 to $4,200,565.62.

Highlighted Stocks Traded by Insiders:

National Health Investors (NHI) - FREE Research Report

Mccabe Robert A Jr, who is Director at National Health Investors, bought 200 shares at $62.85 on June 4, 2014. Following this transaction, the Director owned 2,270 shares meaning that the stake was boosted by 9.66% with the 200-share transaction.

The shares most recently traded at $63.36, up $0.51, or 0.81% since the insider transaction. Historical insider transactions for National Health Investors go as follows:

  • 4-Week # shares bought: 900
  • 12-Week # shares bought: 900
  • 24-Week # shares bought: 1,090

The average volume for National Health Investors has been 179,100 shares per day over the past 30 days. National Health Investors has a market cap of $2.1 billion and is part of the financial sector and real estate industry. Shares are up 11.52% year-to-date as of the close of trading on Wednesday.

National Health Investors, Inc., a real estate investment trust (REIT), invests in health care properties, primarily in the long-term care industry in the United States. The stock currently has a dividend yield of 4.92%. The company has a P/E ratio of 21.0. Currently, there are 2 analysts who rate National Health Investors a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NHI - FREE

TheStreet Quant Ratings rates National Health Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full National Health Investors Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

EPR Properties (EPR) - FREE Research Report

Earnest Morgan G II, who is SVP and CIO at EPR Properties, sold 5,000 shares at $54.43 on June 4, 2014. Following this transaction, the SVP and CIO owned 78,878 shares meaning that the stake was reduced by 5.96% with the 5,000-share transaction.

The shares most recently traded at $55.32, up $0.89, or 1.61% since the insider transaction. Historical insider transactions for EPR Properties go as follows:

  • 4-Week # shares sold: 8,500
  • 12-Week # shares sold: 8,500
  • 24-Week # shares sold: 8,500

The average volume for EPR Properties has been 308,500 shares per day over the past 30 days. EPR Properties has a market cap of $2.9 billion and is part of the financial sector and real estate industry. Shares are up 11.68% year-to-date as of the close of trading on Wednesday.

EPR Properties, a real estate investment trust (REIT), develops, owns, leases, and finances entertainment and related properties in the United States and Canada. Its properties include megaplex theatres, entertainment retail centers, and destination recreational and specialty properties. The stock currently has a dividend yield of 6.24%. The company has a P/E ratio of 17.9. Currently, there are 2 analysts who rate EPR Properties a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EPR - FREE

TheStreet Quant Ratings rates EPR Properties as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, good cash flow from operations, increase in net income and increase in stock price during the past year. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full EPR Properties Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Littelfuse (LFUS) - FREE Research Report

Daniel F Stanek, who is V.P. & G.M. Custom Products at Littelfuse, sold 495 shares at $85.75 on June 4, 2014. Following this transaction, the V.P. & G.M. Custom Products owned 5,100 shares meaning that the stake was reduced by 8.85% with the 495-share transaction.

Historical insider transactions for Littelfuse go as follows:

  • 4-Week # shares sold: 3,647
  • 12-Week # shares sold: 11,759
  • 24-Week # shares sold: 17,609

The average volume for Littelfuse has been 124,500 shares per day over the past 30 days. Littelfuse has a market cap of $1.9 billion and is part of the services sector and wholesale industry. Shares are down 6.83% year-to-date as of the close of trading on Wednesday.

Littelfuse, Inc. designs, manufactures, and sells circuit protection devices for use in the automotive, electronic, and electrical markets worldwide. It operates in three segments: Electronics, Automotive, and Electrical. The stock currently has a dividend yield of 1.03%. The company has a P/E ratio of 18.8. Currently, there is 1 analyst who rates Littelfuse a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LFUS - FREE

TheStreet Quant Ratings rates Littelfuse as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Littelfuse Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

FTC Chair Says Agency Is Ready to Take on Big Tech; Walgreens Joins Dow -- ICYMI

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists